Month: April 2014

Controlling Cholesterol through R&D

Drug developers are spending billions on R&D and extensive studies on treatments for high cholesterol based on genomic sequencing. According to Damian Garde of Fiercebiotech, Amgen is the current leader and may be the first to launch a new drug; the company is...

The Hazards of Office Wellness Programs

According to Jan Wieczner of The Wall Street Journal, approximately 90% of employers provide health care programs with wellness incentives or financial rewards to employees. In 2008, that number was 57%. The programs are designed to encourage employees to take action...